Chinese Journal of Stroke ›› 2020, Vol. 15 ›› Issue (02): 202-208.DOI: 10.3969/j.issn.1673-5765.2020.02.019
Previous Articles Next Articles
Received:
2019-12-12
Online:
2020-02-20
Published:
2020-02-20
马高亭,缪中荣
通讯作者:
缪中荣 zhongrongm@163.com
MA Gao-Ting, MIAO Zhong-Rong. Antiplatelet Therapy in Endovascular Treatment for Ischemic Cerebrovascular Disease[J]. Chinese Journal of Stroke, 2020, 15(02): 202-208.
马高亭,缪中荣. 抗血小板治疗在血管内治疗缺血性脑血管病中的应用[J]. 中国卒中杂志, 2020, 15(02): 202-208.
[1] 《中国脑卒中防治报告2018》编写组. 我国脑卒中防治仍面临巨大挑战——《中国脑卒中防治报告2018》概要[J]. 中国循环杂志,2019,34(2):105-119.[2] LEES K R,BLUHMKI E,VON KUMMER R,etal. Time to treatment with intravenous alteplaseand outcome in stroke:an updated pooled analysisof ECASS,ATLANTIS,NINDS,and EPITHETtrials[J]. Lancet,2010,375(9727):1695-1703.[3] EMBERSON J,LEES K R,LYDEN P,et al. Effectof treatment delay,age,and stroke severity on theeffects of intravenous thrombolysis with alteplase foracute ischaemic stroke:a meta-analysis of individualpatient data from randomised trials[J]. Lancet,2014,384(9958):1929-1935.[4] BHATIA R,HILL M D,SHOBHA N,et al. Lowrates of acute recanalization with intravenousrecombinant tissue plasminogen activator inischemic stroke:real-world experience and a call foraction[J]. Stroke,2010,41(10):2254-2258.[5] BERKHEMER O A,FRANSEN P S,BEUMER D,et al. A randomized trial of intraarterial treatmentfor acute ischemic stroke[J]. N Engl J Med,2015,372(1):11-20.[6] GOYAL M,DEMCHUK A M,MENON B K,etal. Randomized assessment of rapid endovasculartreatment of ischemic stroke[J]. N Engl J Med,2015,372(11):1019-1030.[7] JOVIN T G,CHAMORRO A,COBO E,et al.Thrombectomy within 8 hours after symptom onsetin ischemic stroke[J]. N Engl J Med,2015,372(24):2296-2306.[8] SAVER J L,GOYAL M,BONAFE A,et al. Stentretrieverthrombectomy after intravenous t-PA vs .t-PA alone in stroke[J]. N Engl J Med,2015,372(24):2285-2295.[9] CAMPBELL B C,MITCHELL P J,KLEINIG T J,et al. Endovascular therapy for ischemic stroke withperfusion-imaging selection[J]. N Engl J Med,2015,372(11):1009-1018.[10] 中华医学会神经病学分会,中华医学会神经病学分会脑血管病学组,中华医学会神经病学分会神经血管介入协作组. 中国急性缺血性脑卒中早期血管内介入诊疗指南2018[J]. 中华神经科杂志,2018,51(9):683-691.[11] NOGUEIRA R G,JADHAV A P,HAUSSEN D C,et al. Thrombectomy 6 to 24 hours after stroke witha mismatch between deficit and infarct[J]. N Engl JMed,2018,378(1):11-21.[12] ALBERS G W,MARKS M P,KEMP S,et al.Thrombectomy for stroke at 6 to 16 hours withselection by perfusion imaging[J]. N Engl J Med,2018,378(8):708-718.[13] NAHAB F,KASS-HOUT T,SHALTONI H M.Periprocedural antithrombotic strategies in acuteischemic stroke interventional therapy[J]. Neurology,2012,79(13 Suppl 1):S174-181.[14] 中华预防医学会卒中预防与控制专业委员会介入学组. 缺血性脑血管病介入治疗抗血小板策略中国专家共识[J]. 中华医学杂志,2015,95(11):803-809.[15] 国家卫生健康委脑卒中防治工程委员会,中华医学会神经外科学分会神经介入学组,中华医学会放射学分会介入学组,等. 急性大血管闭塞性缺血性卒中血管内治疗中国专家共识(2019年修订版)[J]. 中华神经外科杂志,2019,35(9):868-879.[16] 中国卒中学会重症脑血管病分会专家撰写组. 急性缺血性脑卒中血管内治疗术后监护与管理中国专家共识[J]. 中华医学杂志,2017,97(3):162-172.[17] 中国卒中学会,中国卒中学会神经介入分会,中华预防医学会卒中预防与控制专业委员会介入学组. 急性缺血性卒中血管内治疗中国指南2018[J]. 中国卒中杂志,2018,13(7):706-729.[18] NAYLOR A R,RICCO J B,DE BORST G J,et al.Management of atherosclerotic carotid and vertebralartery disease:2017 clinical practice guidelines ofthe European Society for Vascular Surgery(ESVS)[J]. Eur J Vasc Endovasc Surg,2018,55(1):3-81.[19] BROEG-MORVAY A,MORDASINI P,SLEZAKA,et al. Does antiplatelet therapy during bridgingthrombolysis increase rates of intracerebralhemorrhage in stroke patients?[J/OL]. PLoS One,2017,12(1):e0170045[2019-12-12]. https://doi.org/10.1371/journal.pone.0170045.[20] JEONG H G,KIM B J,YANG M H,et al. Strokeoutcomes with use of antithrombotics within 24hours after recanalization treatment[J]. Neurology,2016,87(10):996-1002.[21] ALBERS G W,LANSBERG M G,KEMP S,etal. A multicenter randomized controlled trial ofendovascular therapy following imaging evaluationfor ischemic stroke(DEFUSE 3)[J]. Int J Stroke,2017,12(8):896-905.[22] MULDER M J,BERKHEMER O A,FRANSEN PS,et al. Does prior antiplatelet treatment improvefunctional outcome after intra-arterial treatment foracute ischemic stroke?[J]. Int J Stroke,2017,12(4):368-376.[23] PANDHI A,TSIVGOULIS G,KRISHNAN R,etal. Antiplatelet pretreatment and outcomes followingmechanical thrombectomy for emergent large vesselocclusion strokes[J]. J Neurointerv Surg,2018,10(9):828-833.[24] JIA B,FENG L,LIEBESKIND D S,et al.Mechanical thrombectomy and rescue therapy forintracranial large artery occlusion with underlyingatherosclerosis[J]. J Neurointerv Surg,2018,10(8):746-750.[25] ZHAO W,CHE R,SHANG S,et al. Low-dosetirofiban improves functional outcome in acuteischemic stroke patients treated with endovascularthrombectomy[J]. Stroke,2017,48(12):3289-3294.[26] DELGADO F,OTEROS R,JIMENEZ-GOMEZE,et al. Half bolus dose of intravenous abciximabis safe and effective in the setting of acute strokeendovascular treatment[J]. J Neurointerv Surg,2019,11(2):147-152.[27] RANGEL-CASTILLA L,RAJAH G B,SHAKIRH J,et al. Management of acute ischemic strokedue to tandem occlusion:should endovascularrecanalization of the extracranial or intracranialocclusive lesion be done first?[J/OL]. NeurosurgFocus,2017,42(4):E16[2019-12-12]. https://doi.org/10.3171/2017.1.FOCUS16500. [28] BROTT T G,HOBSON R W 2nd,HOWARD G,etal. Stenting versus endarterectomy for treatment ofcarotid-artery stenosis[J]. N Engl J Med,2010,363(1):11-23.[29] BROTT T G,HOWARD G,ROUBIN G S,et al.Long-term results of stenting versus endarterectomyfor carotid-artery stenosis[J]. N Engl J Med,2016,374(11):1021-1031.[30] MCKEVITT F M,RANDALL M S,CLEVELANDT J,et al. The benefits of combined antiplatelettreatment in carotid artery stenting[J]. Eur J VascEndovasc Surg,2005,29(5):522-527.[31] PEETERS W S M,VAN HAELST S T,DENRUIJTER H M,et al. Lack of evidence for dualantiplatelet therapy after endovascular arterialprocedures:a meta-analysis[J]. Eur J Vasc EndovascSurg,2016,52(2):253-262.[32] CHIMOWITZ M I,LYNN M J,DERDEYN C P,etal. Stenting versus aggressive medical therapy forintracranial arterial stenosis[J]. N Engl J Med,2011,365(11):993-1003.[33] DERDEYN C P,CHIMOWITZ M I,LYNN M J,etal. Aggressive medical treatment with or withoutstenting in high-risk patients with intracranialartery stenosis(SAMMPRIS):the final results of arandomised trial[J]. Lancet,2014,383(9914):333-341.[34] DERDEYN C P,FIORELLA D,LYNN M J,et al.Nonprocedural symptomatic infarction and in-stentrestenosis after intracranial angioplasty and stentingin the SAMMPRIS trial(Stenting and AggressiveMedical Management for the Prevention of RecurrentStroke in Intracranial Stenosis)[J]. Stroke,2017,48(6):1501-1506.[35] HASSAN A E,ZACHARATOS H,VAZQUEZG,et al. Low risk of intracranial and systemichemorrhages in patients on dual antiplatelettreatment beyond 1 month followingneuroendovascular angioplasty and/or stentplacement[J]. J Neuroimaging,2012,22(1):67-73.[36] CHEN X,HUANG Q,HONG B,et al. Drug-elutingstent for the treatment of symptomatic vertebralorigin stenosis:long-term results[J]. J Clin Neurosci,2011,18(1):47-51.[37] VAJDA Z,AGUILAR M,GÖHRINGER T,et al.Treatment of intracranial atherosclerotic diseasewith a balloon-expandable paclitaxel eluting stent:procedural safety,efficacy and mid-term patency[J].Clin Neuroradiol,2012,22(3):227-233. |
[1] | WU Yuqian, ZHANG Yumei, FAN Xiaowei, WANG Anxin, PANG Wenbin. The Efficacy of Kinesthetic Motor Imagery Therapy for Hand Function Rehabilitation of Stroke Patients [J]. Chinese Journal of Stroke, 2022, 17(12): 1366-1371. |
[2] | YI Luo, ZHOU Hongyu, QIU Xin, LI Zixiao, WANG Yongjun. DNA Methylation Changes in Atherosclerotic Diseases [J]. Chinese Journal of Stroke, 2022, 17(11): 1163-1170. |
[3] | WANG Yubo, LI Zixiao, WANG Yongjun. Progress of the Relationship between Epigenetics and Oxidative Stress after Ischemic Stroke [J]. Chinese Journal of Stroke, 2022, 17(11): 1171-1177. |
[4] | CUI Lingyun, QIU Xin, ZHOU Hongyu, LI Zixiao, WANG Yongjun. Progress of the Relationship between DNA Methylation and Type 2 Diabetes [J]. Chinese Journal of Stroke, 2022, 17(11): 1183-1188. |
[5] | LIU Guangliang, HAN Kaiyue, SU Wenlong, ZHANG Hao. Effects of Aerobic Cycling Training Intensity on Motor and Cardiopulmonary Fitness in Patients with Ischemic Stroke [J]. Chinese Journal of Stroke, 2022, 17(11): 1203-1208. |
[6] | XU Yingxin, ZHANG Shuang, ZHOU Xiaomei, YUAN Jinglin, ZHAO Liuzhuang, YANG Haihua. Correlation of Non-Stenotic Carotid Plaque with Anterior Circulation Embolic Stroke of Undetermined Source [J]. Chinese Journal of Stroke, 2022, 17(11): 1233-1237. |
[7] | CHENG Shi, LI Jing, GUO Junping, HU Aixiang, YU Xinwei, HAN Wei, LIANG Ying, ZHANG Yuewei, JI Ruijun. Clinical Characteristics and Risk Factors of Infection in Patients with Acute Stroke during Hospitalization [J]. Chinese Journal of Stroke, 2022, 17(10): 1065-1070. |
[8] | XIANG Wei, XU Luyao, ZHANG Manman, WEI Hongchun, LIANG Zhigang. The Frequency and Influencing Factors of Asymmetrical Prominent Veins Sign on Susceptibility-Weighted Imaging in Acute Ischemic Stroke [J]. Chinese Journal of Stroke, 2022, 17(10): 1097-1102. |
[9] | ZHAO Yongrui, LIU Zhanhui. Progress of Diffusion Tensor Imaging in Evaluating Motor Function Prognosis of Patients with Ischemic Stroke [J]. Chinese Journal of Stroke, 2022, 17(10): 1114-1119. |
[10] | ZHANG Boyu, GUO Yucheng, CUI Yuxia, LI Yingli, LYU Yumei. Seeking Medical Services Decision-Making Status and Relevant Influencing Factors in Patients with Acute Ischemic Stroke: A Review [J]. Chinese Journal of Stroke, 2022, 17(10): 1127-1132. |
[11] | WU Tingting, LIU Yafei, YAN Shixi, WU Yiping, ZHANG Zhongbo, ZAHNG Hanfei, FANG Pinping. Application of “Internet Plus” in Emergency Care of Acute Ischemic Stroke [J]. Chinese Journal of Stroke, 2022, 17(10): 1133-1138. |
[12] | ZHANG Yige, ZHANG Wan, ZHANG Luyang, WANG Xin, DING Lan, WANG Yuying, PEI Lulu, FANG Hui, XU Yuming, SONG Bo. Association of Artery Occlusion and Recurrent Ischemic Stroke Related with Cerebral Artery Dissection [J]. Chinese Journal of Stroke, 2022, 17(09): 932-936. |
[13] | LYU Wei, WANG Anxin, TIAN Xue, ZHANG Xiaoli, XU Yuyuan, MENG Xia. Effect of Xinxuening Capsule on Short-term Functional Outcome in Patients with Ischemic Stroke and High Homocysteine Level [J]. Chinese Journal of Stroke, 2022, 17(09): 972-976. |
[14] | ZHANG Xinmiao, PAN Yuesong, XIANG Xianglong, WANG Yongjun, MENG Xia. Early Clinical Pathway Intervention to Improve the Key Performance Indicators of Medical Care for Ischemic Stroke [J]. Chinese Journal of Stroke, 2022, 17(09): 977-984. |
[15] | GONG Yutian, LI Jiejie. Advances in the Relationship between IL-6 and Atherosclerotic Ischemic Stroke [J]. Chinese Journal of Stroke, 2022, 17(09): 1022-1026. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||